CD4 and myeloid sarcoma: We also observed upregulation of MHC class II and several co-stimulatory molecules in our microarray and further studies need to be performed to further interrogate this pathway since examination of the ability of OPCs to activate CD4+ T cells is clearly of relevance to MS.